Representative imaging of macular drusen reduction following photobiomodulation treatment.
Photobiomodulation is a light-based therapy that uses specific wavelengths of visible to near-infrared light (590, 660, and 850 nm) to stimulate cellular repair and reduce inflammation in retinal tissue.
PBM targets mitochondrial dysfunction, one of the known contributors to Dry AMD, while:
This unique approach helps improve retinal structure and function and may reduce the risk of geographic atrophy (GA) development.
The LIGHTSITE III clinical trial evaluated multiwavelength PBM therapy in 100 patients across 10 centers. Participants received PBM treatment using the LumiThera Valeda Light Delivery System. After a 13-Month Analysis, it was discovered:
These outcomes demonstrate PBM’s potential as a disease-modifying treatment for early to intermediate Dry AMD.
Early intervention is key. The sooner AMD is detected, the better the chance of slowing or reversing damage. At Urban Optics, we offer advanced diagnostics and access to the latest non-invasive treatment options for retinal care. Contact us today to book your comprehensive macular evaluation and learn whether PBM therapy is appropriate for your eye health.
You might be eligible for PBM Treatment if you:
Photobiomodulation (PBM) is an entirely non-invasive treatment. It uses low-level light to gently stimulate retinal cells without any injections, incisions, or physical contact with the eye. Most patients find it comfortable and quick, with no downtime after each session.
Menu
